Preventative health technology company Viome Life Sciences has acquired Circulate Health, which has pioneered a therapeutic plasma exchange outside the hospital setting. Viome says the move will integrate its molecular diagnostics and precision nutrition platform with Circulate’s physician-facilitated therapeutic plasma exchange and its network of clinical partners in the US. As the science of measuring biological aging, inflammation, metabolism, and the gut microbiome advances, the company highlights an opportunity to widen what clinicians can do with that information.